
Celeste A. Roney
Examiner (ID: 16321, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 882 |
| Issued Applications | 480 |
| Pending Applications | 120 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18229893
[patent_doc_number] => 20230068887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => MODULATION OF THE NITRIC OXIDE SYNTHASE PATHWAY FOR ORAL HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/948184
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948184 | Modulation of the nitric oxide synthase pathway for oral health | Sep 18, 2022 | Issued |
Array
(
[id] => 20005800
[patent_doc_number] => 20250144022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TNFAlpha ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 18/691121
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691121
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691121 | PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TNFAlpha ANTIBODY | Sep 14, 2022 | Pending |
Array
(
[id] => 19570490
[patent_doc_number] => 20240374782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => SPONGE-LIKE SCAFFOLD FOR PROMOTING HAEMOSTASIS
[patent_app_type] => utility
[patent_app_number] => 18/691129
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691129 | SPONGE-LIKE SCAFFOLD FOR PROMOTING HAEMOSTASIS | Sep 13, 2022 | Pending |
Array
(
[id] => 19343715
[patent_doc_number] => 20240252678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/292846
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -102
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292846
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292846 | SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS | Sep 11, 2022 | Pending |
Array
(
[id] => 18565687
[patent_doc_number] => 20230256014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHODS OF GENERATING CROSS-LINKED PROTEIN FOAMS IN SITU
[patent_app_type] => utility
[patent_app_number] => 17/930872
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930872 | Methods of generating cross-linked protein foams in situ | Sep 8, 2022 | Issued |
Array
(
[id] => 18160899
[patent_doc_number] => 20230027491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TERMITE REPELLENT AND WOOD PROTECTOR
[patent_app_type] => utility
[patent_app_number] => 17/903989
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17903989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/903989 | Termite repellent and wood protector | Sep 5, 2022 | Issued |
Array
(
[id] => 18610067
[patent_doc_number] => 20230276795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => TERMITE REPELLANT AND WOOD PROTECTOR
[patent_app_type] => utility
[patent_app_number] => 17/903974
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17903974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/903974 | Termite repellant and wood protector | Sep 5, 2022 | Issued |
Array
(
[id] => 19599367
[patent_doc_number] => 20240390247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => MAKEUP KIT COMPRISING AN AQUEOUS MAKEUP COMPOSITION AND A CONTINUOUS OILY-PHASE FIXING COMPOSITION WITH A HYDROPHOBIC FILM-FORMING POLYMER
[patent_app_type] => utility
[patent_app_number] => 18/690391
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690391
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690391 | MAKEUP KIT COMPRISING AN AQUEOUS MAKEUP COMPOSITION AND A CONTINUOUS OILY-PHASE FIXING COMPOSITION WITH A HYDROPHOBIC FILM-FORMING POLYMER | Aug 31, 2022 | Pending |
Array
(
[id] => 18229475
[patent_doc_number] => 20230068469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => EVALUATING DRUG EFFICACY BY USING WEARABLE SENSORS
[patent_app_type] => utility
[patent_app_number] => 17/899194
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899194 | Evaluating drug efficacy by using wearable sensors | Aug 29, 2022 | Issued |
Array
(
[id] => 19541607
[patent_doc_number] => 20240358643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => AN AMORPHOUS SOLID DISPERSION OF A QUINOLONE COMPOUND AND PROCESS FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/292235
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292235
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292235 | AN AMORPHOUS SOLID DISPERSION OF A QUINOLONE COMPOUND AND PROCESS FOR THE PREPARATION THEREOF | Aug 25, 2022 | Pending |
Array
(
[id] => 18467086
[patent_doc_number] => 20230201367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => LAYER-BY-LAYER NANOPARTICLES FOR CYTOKINE THERAPY IN CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/892496
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892496 | Layer-by-layer nanoparticles for cytokine therapy in cancer treatment | Aug 21, 2022 | Issued |
Array
(
[id] => 19830888
[patent_doc_number] => 20250082674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/292042
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292042
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292042 | METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS | Aug 16, 2022 | Pending |
Array
(
[id] => 19996602
[patent_doc_number] => 20250134824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/683531
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683531
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683531 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | Aug 15, 2022 | Pending |
Array
(
[id] => 19388022
[patent_doc_number] => 20240277892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => FABRICATION AND APPLICATION OF FIBER-BASED HYDROGEL USING ALL-AQUEOUS FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/571747
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571747 | FABRICATION AND APPLICATION OF FIBER-BASED HYDROGEL USING ALL-AQUEOUS FORMULATIONS | Aug 2, 2022 | Pending |
Array
(
[id] => 19844372
[patent_doc_number] => 20250089723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => BIOCONTROL AGENT AND METHOD FOR REDUCING THE OCCURRENCE AND IMPACTS OF APHANOMYCES EUTEICHES
[patent_app_type] => utility
[patent_app_number] => 18/291944
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291944
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291944 | BIOCONTROL AGENT AND METHOD FOR REDUCING THE OCCURRENCE AND IMPACTS OF APHANOMYCES EUTEICHES | Jul 28, 2022 | Pending |
Array
(
[id] => 19845084
[patent_doc_number] => 20250090435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/291721
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291721
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291721 | PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS | Jul 28, 2022 | Pending |
Array
(
[id] => 18056266
[patent_doc_number] => 20220387352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/874890
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874890 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | Jul 26, 2022 | Abandoned |
Array
(
[id] => 19541849
[patent_doc_number] => 20240358885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => COMPOSITIONS FOR EMBOLIZATION
[patent_app_type] => utility
[patent_app_number] => 18/292107
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292107 | COMPOSITIONS FOR EMBOLIZATION | Jul 24, 2022 | Pending |
Array
(
[id] => 19554730
[patent_doc_number] => 20240366522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM
[patent_app_type] => utility
[patent_app_number] => 18/291710
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291710 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | Jul 24, 2022 | Pending |
Array
(
[id] => 19273204
[patent_doc_number] => 12023311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/868323
[patent_app_country] => US
[patent_app_date] => 2022-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 34013
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17868323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/868323 | Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof | Jul 18, 2022 | Issued |